Advaite Gets FDA Emergency Use Clearance for 15-Minute COVID-19 Test

Advaite has been handed Emergency Use Authorization from the FDA for RapCov, a rapid IgG antibody test for COVID-19.

The serology test uses a single drop of fingertip blood to detect IgG antibodies to the virus in 15 minutes in point-of-care settings, meaning it does not require any offsite lab work.

The Malvern, Pa.-based diagnostics maker said that it intends to immediately begin supplying the U.S. market with the test kit on a national scale but did not say how much the test will cost.